nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—Dapsone—leprosy	0.329	0.411	CbGbCtD
Aminosalicylic Acid—PTGS2—Thalidomide—leprosy	0.142	0.177	CbGbCtD
Aminosalicylic Acid—PTGS1—Thalidomide—leprosy	0.12	0.15	CbGbCtD
Aminosalicylic Acid—PTGS2—Dapsone—leprosy	0.114	0.142	CbGbCtD
Aminosalicylic Acid—PTGS1—Dapsone—leprosy	0.096	0.12	CbGbCtD
Aminosalicylic Acid—Infectious mononucleosis—Dapsone—leprosy	0.0552	0.586	CcSEcCtD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL23R—leprosy	0.00695	0.0761	CbGpPWpGaD
Aminosalicylic Acid—Pericarditis—Thalidomide—leprosy	0.00394	0.0418	CcSEcCtD
Aminosalicylic Acid—CHUK—Endogenous TLR signaling—TLR1—leprosy	0.00374	0.0409	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—CYLD—leprosy	0.00306	0.0334	CbGpPWpGaD
Aminosalicylic Acid—Hypothyroidism—Thalidomide—leprosy	0.00265	0.0281	CcSEcCtD
Aminosalicylic Acid—CHUK—NOD1/2 Signaling Pathway—CYLD—leprosy	0.00241	0.0263	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—RIPK2—leprosy	0.00197	0.0216	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Endogenous TLR signaling—TLR2—leprosy	0.0019	0.0208	CbGpPWpGaD
Aminosalicylic Acid—Neuropathy peripheral—Dapsone—leprosy	0.00182	0.0194	CcSEcCtD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—NOD2—leprosy	0.00179	0.0195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RIPK2—leprosy	0.00179	0.0195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —CYLD—leprosy	0.00176	0.0192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—leprosy	0.00164	0.018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NOD2—leprosy	0.00162	0.0177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NOD1/2 Signaling Pathway—RIPK2—leprosy	0.00155	0.017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—LTA—leprosy	0.00154	0.0168	CbGpPWpGaD
Aminosalicylic Acid—MPO—blood vessel—leprosy	0.00147	0.113	CbGeAlD
Aminosalicylic Acid—CHUK—skin of body—leprosy	0.00143	0.11	CbGeAlD
Aminosalicylic Acid—CHUK—NOD1/2 Signaling Pathway—NOD2—leprosy	0.00141	0.0154	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—hindlimb—leprosy	0.0014	0.107	CbGeAlD
Aminosalicylic Acid—Vascular purpura—Thalidomide—leprosy	0.00138	0.0147	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Thalidomide—leprosy	0.00131	0.0139	CcSEcCtD
Aminosalicylic Acid—Purpura—Thalidomide—leprosy	0.00128	0.0136	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Thalidomide—leprosy	0.00127	0.0134	CcSEcCtD
Aminosalicylic Acid—CHUK—Interleukin-1 signaling—RIPK2—leprosy	0.00127	0.0138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NOD pathway—RIPK2—leprosy	0.00124	0.0136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream TCR signaling—RIPK2—leprosy	0.00124	0.0136	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00124	0.0131	CcSEcCtD
Aminosalicylic Acid—PTGS2—appendage—leprosy	0.0012	0.0922	CbGeAlD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.00117	0.0129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Interleukin-1 signaling—NOD2—leprosy	0.00115	0.0125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—leprosy	0.00113	0.0123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NOD pathway—NOD2—leprosy	0.00112	0.0123	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IFNG—leprosy	0.00111	0.0121	CbGpPWpGaD
Aminosalicylic Acid—Abdominal distension—Thalidomide—leprosy	0.00108	0.0114	CcSEcCtD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—CD4—leprosy	0.00107	0.0117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RIPK2—leprosy	0.00106	0.0116	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—skin epidermis—leprosy	0.000999	0.0767	CbGeAlD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—IL2—leprosy	0.000983	0.0108	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Dapsone—leprosy	0.000971	0.0103	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Thalidomide—leprosy	0.000967	0.0103	CcSEcCtD
Aminosalicylic Acid—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—leprosy	0.000959	0.0105	CbGpPWpGaD
Aminosalicylic Acid—Body temperature increased—Dapsone—leprosy	0.000938	0.00995	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dapsone—leprosy	0.000938	0.00995	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Thalidomide—leprosy	0.000934	0.00991	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR signaling—RIPK2—leprosy	0.000927	0.0101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.000917	0.01	CbGpPWpGaD
Aminosalicylic Acid—CHUK—testis—leprosy	0.000903	0.0693	CbGeAlD
Aminosalicylic Acid—Agranulocytosis—Thalidomide—leprosy	0.000889	0.00943	CcSEcCtD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—IFNG—leprosy	0.000856	0.00937	CbGpPWpGaD
Aminosalicylic Acid—Hepatitis—Thalidomide—leprosy	0.000855	0.00907	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Thalidomide—leprosy	0.000845	0.00896	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Thalidomide—leprosy	0.000838	0.00889	CcSEcCtD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—RIPK2—leprosy	0.000818	0.00895	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—CD8A—leprosy	0.000765	0.00838	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream TCR signaling—HLA-DRB1—leprosy	0.000765	0.00837	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—RIPK2—leprosy	0.000765	0.00837	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Dapsone—leprosy	0.000755	0.00801	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Thalidomide—leprosy	0.000744	0.0079	CcSEcCtD
Aminosalicylic Acid—Headache—Dapsone—leprosy	0.000744	0.00789	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—leprosy	0.000743	0.00813	CbGpPWpGaD
Aminosalicylic Acid—Flatulence—Thalidomide—leprosy	0.000734	0.00778	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Thalidomide—leprosy	0.000729	0.00773	CcSEcCtD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.000725	0.00793	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—TNF—leprosy	0.000716	0.00784	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Dapsone—leprosy	0.000705	0.00748	CcSEcCtD
Aminosalicylic Acid—PTGS1—blood vessel—leprosy	0.0007	0.0537	CbGeAlD
Aminosalicylic Acid—MPO—Folate Metabolism—IFNG—leprosy	0.000696	0.00762	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—leprosy	0.000694	0.00759	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 cascade initiated on plasma membrane—RIPK2—leprosy	0.000692	0.00757	CbGpPWpGaD
Aminosalicylic Acid—Anaemia—Thalidomide—leprosy	0.000688	0.0073	CcSEcCtD
Aminosalicylic Acid—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—leprosy	0.000686	0.0075	CbGpPWpGaD
Aminosalicylic Acid—MPO—skin of body—leprosy	0.000683	0.0524	CbGeAlD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—RIPK2—leprosy	0.000673	0.00737	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—blood vessel—leprosy	0.000669	0.0513	CbGeAlD
Aminosalicylic Acid—Leukopenia—Thalidomide—leprosy	0.000666	0.00707	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—RIPK2—leprosy	0.000661	0.00724	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—leprosy	0.00065	0.00711	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—TLR2—leprosy	0.000639	0.00699	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—RIPK2—leprosy	0.000639	0.00699	CbGpPWpGaD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000629	0.00668	CcSEcCtD
Aminosalicylic Acid—CHUK—MyD88 cascade initiated on plasma membrane—NOD2—leprosy	0.000628	0.00687	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—leprosy	0.000622	0.0068	CbGpPWpGaD
Aminosalicylic Acid—MPO—Folate Metabolism—IL2—leprosy	0.000619	0.00677	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—RIPK2—leprosy	0.000613	0.0067	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—NOD2—leprosy	0.00061	0.00668	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.000598	0.00655	CbGpPWpGaD
Aminosalicylic Acid—Nervous system disorder—Thalidomide—leprosy	0.000596	0.00632	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Thalidomide—leprosy	0.000595	0.00631	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Thalidomide—leprosy	0.00059	0.00626	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—NOD2—leprosy	0.000589	0.00645	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Thalidomide—leprosy	0.000579	0.00614	CcSEcCtD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—NOD2—leprosy	0.000579	0.00634	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—TNF—leprosy	0.000575	0.00629	CbGpPWpGaD
Aminosalicylic Acid—CHUK—EBV LMP1 signaling—TNF—leprosy	0.000575	0.00629	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling—HLA-DRB1—leprosy	0.000572	0.00626	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—RIPK2—leprosy	0.000571	0.00625	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—NOD2—leprosy	0.000555	0.00608	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—CD4—leprosy	0.000555	0.00607	CbGpPWpGaD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—TNF—leprosy	0.000554	0.00606	CbGpPWpGaD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—IFNG—leprosy	0.000553	0.00605	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—RIPK2—leprosy	0.000551	0.00603	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—TLR2—leprosy	0.000551	0.00603	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream TCR signaling—CD4—leprosy	0.00054	0.00591	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—SDHD—leprosy	0.00054	0.00591	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Thalidomide—leprosy	0.000528	0.0056	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Thalidomide—leprosy	0.000525	0.00556	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—HLA-DRB1—leprosy	0.000523	0.00572	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—IFNG—leprosy	0.000522	0.00571	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—TLR2—leprosy	0.000518	0.00567	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—RIPK2—leprosy	0.000518	0.00567	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—NOD2—leprosy	0.000518	0.00567	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—testis—leprosy	0.000509	0.039	CbGeAlD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—CD8A—leprosy	0.000501	0.00548	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—NOD2—leprosy	0.0005	0.00547	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Overview of nanoparticle effects—TNF—leprosy	0.000499	0.00547	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—nervous system—leprosy	0.000499	0.0383	CbGeAlD
Aminosalicylic Acid—Gastrointestinal pain—Thalidomide—leprosy	0.000497	0.00527	CcSEcCtD
Aminosalicylic Acid—Urticaria—Thalidomide—leprosy	0.000483	0.00512	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.00048	0.00526	CbGpPWpGaD
Aminosalicylic Acid—Body temperature increased—Thalidomide—leprosy	0.00048	0.0051	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Thalidomide—leprosy	0.00048	0.0051	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—NOD2—leprosy	0.00047	0.00514	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.000467	0.00511	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—RIPK2—leprosy	0.000462	0.00505	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—TLR2—leprosy	0.000462	0.00505	CbGpPWpGaD
Aminosalicylic Acid—MPO—Folate Metabolism—TNF—leprosy	0.000451	0.00493	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Thalidomide—leprosy	0.000448	0.00475	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—leprosy	0.000437	0.00478	CbGpPWpGaD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—leprosy	0.00043	0.00471	CbGpPWpGaD
Aminosalicylic Acid—MPO—testis—leprosy	0.00043	0.033	CbGeAlD
Aminosalicylic Acid—MPO—nervous system—leprosy	0.000422	0.0324	CbGeAlD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—NOD2—leprosy	0.000419	0.00458	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Thalidomide—leprosy	0.000416	0.00441	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR signaling—CD4—leprosy	0.000403	0.00441	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Thalidomide—leprosy	0.000402	0.00426	CcSEcCtD
Aminosalicylic Acid—PTGS2—Overview of nanoparticle effects—TNF—leprosy	0.000397	0.00434	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—leprosy	0.000388	0.00425	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Thalidomide—leprosy	0.000386	0.0041	CcSEcCtD
Aminosalicylic Acid—Rash—Thalidomide—leprosy	0.000383	0.00406	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Thalidomide—leprosy	0.000383	0.00406	CcSEcCtD
Aminosalicylic Acid—Headache—Thalidomide—leprosy	0.000381	0.00404	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—CD4—leprosy	0.000369	0.00404	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Thalidomide—leprosy	0.000361	0.00383	CcSEcCtD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—TNF—leprosy	0.000358	0.00392	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—TNF—leprosy	0.000355	0.00388	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—TNF—leprosy	0.000338	0.0037	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —TNF—leprosy	0.00033	0.00361	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—skin of body—leprosy	0.000324	0.0249	CbGeAlD
Aminosalicylic Acid—PTGS2—skin of body—leprosy	0.00031	0.0238	CbGeAlD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—CD4—leprosy	0.000288	0.00315	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—TNF—leprosy	0.000286	0.00313	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	0.000283	0.00309	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—RIPK2—leprosy	0.000267	0.00292	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—RIPK2—leprosy	0.000262	0.00287	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	0.000251	0.00275	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—tendon—leprosy	0.000247	0.0189	CbGeAlD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NOD2—leprosy	0.000242	0.00265	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—tendon—leprosy	0.000236	0.0181	CbGeAlD
Aminosalicylic Acid—CHUK—Innate Immune System—CYLD—leprosy	0.000232	0.00254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL2—leprosy	0.000229	0.0025	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IFNG—leprosy	0.000226	0.00248	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—SDHD—leprosy	0.000212	0.00231	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—testis—leprosy	0.000204	0.0157	CbGeAlD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—leprosy	0.000204	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—leprosy	0.000204	0.00223	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—nervous system—leprosy	0.0002	0.0154	CbGeAlD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PARK2—leprosy	0.000197	0.00216	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—leprosy	0.000195	0.00214	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—nervous system—leprosy	0.000192	0.0147	CbGeAlD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—leprosy	0.00019	0.00207	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—leprosy	0.000183	0.002	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CD4—leprosy	0.00018	0.00197	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IFNG—leprosy	0.00018	0.00197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.000175	0.00191	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000165	0.0018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—RIPK2—leprosy	0.00015	0.00164	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TLR2—leprosy	0.00015	0.00164	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—leprosy	0.000147	0.0016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—RIPK2—leprosy	0.000144	0.00157	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IFNG—leprosy	0.000142	0.00156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.000136	0.00149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NOD2—leprosy	0.000136	0.00148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CYLD—leprosy	0.000135	0.00148	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL2—leprosy	0.000126	0.00138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IFNG—leprosy	0.00012	0.00132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PARK2—leprosy	0.000119	0.00131	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—leprosy	0.000116	0.00127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SLC11A1—leprosy	0.00011	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD40LG—leprosy	0.00011	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—leprosy	0.000109	0.00119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—leprosy	0.000107	0.00117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—leprosy	0.000106	0.00116	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—leprosy	9.2e-05	0.00101	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SDHD—leprosy	9.17e-05	0.001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DRB1—leprosy	8.86e-05	0.00097	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RIPK2—leprosy	8.71e-05	0.000953	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR2—leprosy	8.71e-05	0.000953	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NOD2—leprosy	7.9e-05	0.000864	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SDHD—leprosy	7.28e-05	0.000797	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40LG—leprosy	6.68e-05	0.000731	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—leprosy	6.6e-05	0.000722	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC11A1—leprosy	6.54e-05	0.000715	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—leprosy	6.51e-05	0.000712	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—leprosy	6.26e-05	0.000685	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—leprosy	6.25e-05	0.000684	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RIPK2—leprosy	5.63e-05	0.000616	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRB1—leprosy	5.38e-05	0.000588	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—leprosy	3.93e-05	0.00043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—leprosy	3.79e-05	0.000415	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—leprosy	3.5e-05	0.000383	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—leprosy	3.49e-05	0.000382	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—leprosy	2.26e-05	0.000247	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—leprosy	2.07e-05	0.000227	CbGpPWpGaD
